Aspen 2013

Reviewed provisional Group financial results for the year ended 30 June 2013

Issue link: http://www.pads.eezeepage.co.za/i/169476

Contents of this Issue

Navigation

Page 1 of 19

www.aspenpharma.com Aspen Pharmacare Holdings Limited ("Aspen") (Registration number 1985/002935/06) Share code: APN ISIN: ZAE000066692 Revenue from continuing operations increased 27% to Operating profit from continuing operations increased 28% to Offshore contribution increased to Normalised diluted headline earnings per share from continuing operations increased 31% to R19,3 billion 63% of Group operating profit R5,0 billion 836,2 cents Diluted cash flow per share from continuing operations increased 37% to Headline earnings per share increased 21% to 874,1 cents 788,0 cents Earnings per share increased 20% to Distribution to shareholders of 773,0 cents generated at BeQRious.com 157 cents per share

Articles in this issue

Links on this page

Archives of this issue

view archives of Aspen 2013 - Reviewed provisional Group financial results for the year ended 30 June 2013